Koers Hypertension Diagnostics, Inc.
Aandelen
HDII
US44914V1044
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0001 USD | +9.900,00% |
|
0,00% | -90,00% |
6 maanden | -92,31% | ||
Lopend jaar | -90,00% |
Omzet 2017 | 3,68 mln. 3,44 mln. | Omzet 2018 | 3,79 mln. 3,55 mln. | Marktkapitalisatie | 92,08K 86,13K |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 | Nettowinst (verlies) 2018 | - 0 | EV/omzet 2017 | 1,15 x |
Nettoschuld 2017 | 4,13 mln. 3,87 mln. | Nettoschuld 2018 | 4,6 mln. 4,3 mln. | EV/omzet 2018 | 1,24 x |
K/w-verhouding 2017 |
-0,28
x | K/w-verhouding 2018 |
-0,54
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
1 dag | +9.900,00% | ||
6 maanden | -92,31% | ||
Lopend jaar | -90,00% |
![Extreem 0.0001](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-90,00% | 28,48K | |
+6,37% | 216 mld. | |
+10,21% | 189 mld. | |
+28,22% | 153 mld. | |
+34,42% | 114 mld. | |
+0,80% | 63,2 mld. | |
+19,21% | 54,78 mld. | |
+0,13% | 48,47 mld. | |
-4,16% | 38,88 mld. | |
+2,39% | 36,14 mld. |